PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Pain 409,851 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.48
Infection 766,637 Disease Target 11-Beta-Hydroxylase 721 2 0.00 -1.00 0.00 0.48
Renal Failure 73,993 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Epilepsy 71,172 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Prostate Cancer 71,064 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Sepsis 64,798 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.52
Diarrhea 51,986 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.52
Seizure 44,685 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.53
Meningitis 41,685 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.53
Obesity 138,233 Disease Target 11-Beta-Hydroxylase 721 2 0.00 -1.00 0.00 0.52
Arrhythmia 29,330 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Platelet Aggregation 25,460 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Dehydration 21,928 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Diabetes 332,602 Disease Target 11-Beta-Hydroxylase 721 4 0.00 -1.00 0.01 0.51
Endometriosis 16,342 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.55
Dyslipidemia 15,225 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.55
Shock 134,031 Disease Target 11-Beta-Hydroxylase 721 3 0.00 -1.00 0.00 0.53
Anxiety 113,510 Disease Target 11-Beta-Hydroxylase 721 3 0.00 -1.00 0.00 0.53
Major Depressive Disorder 12,517 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.56
Cancer 1,053,491 Disease Target 11-Beta-Hydroxylase 721 10 0.00 -0.99 0.01 0.51
Brain Injury 34,874 Disease Target 11-Beta-Hydroxylase 721 2 0.00 -1.00 0.00 0.55
Hemorrhage 100,979 Disease Target 11-Beta-Hydroxylase 721 4 0.00 -1.00 0.01 0.54
Hyperbilirubinemia 5,757 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.58
Hypoglycemia 20,698 Disease Target 11-Beta-Hydroxylase 721 2 0.00 -1.00 0.00 0.56
Hyperprolactinemia 4,112 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.59
Stroke 146,992 Disease Target 11-Beta-Hydroxylase 721 6 0.00 -1.00 0.01 0.54
Depression 220,092 Disease Target 11-Beta-Hydroxylase 721 8 0.00 -0.99 0.01 0.54
Sedation 27,984 Disease Target 11-Beta-Hydroxylase 721 3 0.00 -1.00 0.00 0.56
Hypotension 42,123 Disease Target 11-Beta-Hydroxylase 721 4 0.00 -1.00 0.01 0.56
Carcinoma 433,099 Disease Target 11-Beta-Hydroxylase 721 19 0.00 -0.99 0.03 0.54
Acne 11,364 Disease Target 11-Beta-Hydroxylase 721 5 0.00 -1.00 0.01 0.61
Gynecomastia 2,594 Disease Target 11-Beta-Hydroxylase 721 7 0.01 -0.99 0.01 0.67
Cholesterol 182,390 Disease Target 11-Beta-Hydroxylase 721 98 0.01 -0.93 0.14 0.61
Colon Cancer 30,064 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 2 0.00 -1.00 0.01 0.57
Non Small Cell Lung Cancer 28,563 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 2 0.00 -1.00 0.01 0.58
Lung Cancer 91,416 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 4 0.00 -0.99 0.02 0.56
Diabetes 332,602 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 9 0.00 -0.98 0.04 0.55
Diabetes 332,602 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.52
Obesity 138,233 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.53
Colon Cancer 30,064 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
Cervical Cancer 28,286 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
Conjunctivitis 8,825 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.60
Infection 766,637 Disease Target 4-1BB Ligand 135 11 0.00 -0.96 0.08 0.55
Graft Versus Host Disease 15,741 Disease Target 4-1BB Ligand 135 2 0.00 -0.99 0.01 0.60
Carcinoma 433,099 Disease Target 4-1BB Ligand 135 14 0.00 -0.95 0.10 0.57
Cancer 1,053,491 Disease Target 4-1BB Ligand 135 27 0.00 -0.89 0.20 0.56
Carcinoma 433,099 Disease Target 4-1BB Receptor 20 3 0.00 -0.92 0.15 0.56
Cancer 1,053,491 Disease Target 4-1BB Receptor 20 5 0.00 -0.87 0.25 0.56
Graft Versus Host Disease 15,741 Disease Target 4-1BB Receptor 20 2 0.00 -0.95 0.10 0.63
Carcinoma 433,099 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.52
Cancer 1,053,491 Disease Drug 4-Mercaptobenzoic Acid 70 4 0.00 -0.97 0.06 0.53
Dehydration 21,928 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.59
Hepatitis B 57,815 Disease Drug 4-Mercaptobenzoic Acid 70 2 0.00 -0.99 0.03 0.58
Carcinoma 433,099 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.54
Diabetes 332,602 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.55
Cancer 1,053,491 Disease Target 464.1 19 2 0.00 -0.95 0.11 0.54
Renal Failure 73,993 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Prostate Cancer 71,064 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Acute Promyelocytic Leukemia 4,780 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.65
Cancer 1,053,491 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Infection 766,637 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Diabetes 332,602 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.53
Arthritis 128,324 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Anxiety 113,510 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Rheumatoid Arthritis 78,952 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.56
Headache 50,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Analgesia 44,857 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Seizure 44,685 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Obesity 138,233 Disease Target 5-Hydroxytryptamine 2a Receptor 67 2 0.00 -0.98 0.03 0.56
Attention Deficit Hyperactivity Disorder 14,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Eating Disorders 9,000 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Depression 220,092 Disease Target 5-Hydroxytryptamine 2a Receptor 67 5 0.00 -0.96 0.07 0.57
Obsessive Compulsive Disorder 8,508 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Hyperglycemia 28,168 Disease Target 5-Hydroxytryptamine 2a Receptor 67 2 0.00 -0.98 0.03 0.60
Platelet Aggregation 25,460 Disease Target 5-Hydroxytryptamine 2a Receptor 67 3 0.00 -0.98 0.04 0.61
Insomnia 12,434 Disease Target 5-Hydroxytryptamine 2a Receptor 67 3 0.00 -0.98 0.04 0.63
Schizophrenia 77,034 Disease Target 5-Hydroxytryptamine 2a Receptor 67 10 0.00 -0.92 0.15 0.61
Obesity 138,233 Disease Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.57
Diabetes 332,602 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.55
Analgesia 44,857 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.59
Tuberculosis 146,217 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.51
Anxiety 113,510 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.52
Diabetes 332,602 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.51
Influenza 67,933 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.53
Diarrhea 51,986 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.54
Osteoarthritis 36,287 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Shock 134,031 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.53
Colon Cancer 30,064 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Non Small Cell Lung Cancer 28,563 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Cervical Cancer 28,286 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Hemorrhage 100,979 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.54
Multiple Myeloma 24,594 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.56
Pneumonia 81,521 Disease Target A1AT 329 3 0.00 -1.00 0.01 0.55
Obesity 138,233 Disease Target A1AT 329 4 0.00 -0.99 0.01 0.55
Fibromyalgia 6,837 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.59
Kidney Diseases 4,651 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.60
Infection 766,637 Disease Target A1AT 329 16 0.00 -0.98 0.05 0.54
Bladder Cancer 21,509 Disease Target A1AT 329 3 0.00 -1.00 0.01 0.59
Lung Cancer 91,416 Disease Target A1AT 329 7 0.00 -0.99 0.02 0.57
Hepatitis B 57,815 Disease Target A1AT 329 6 0.00 -0.99 0.02 0.58